After a year marked by apparent sales rebounds—but few fundamental changes—many life sciences companies face a critical question: Are we building something truly sustainable, or just engineering short-term wins?
In 5 minutes, you'll be able to assess whether your current commercial strategy is truly designed for reliable growth—or whether you're at risk of falling behind in the new healthcare economy.
You’ll answer 12 quick questions across three pillars:
Points will be tallied as you go. At the end, you’ll be able to compare your score to the scoring guide to identify where your organization currently stands—and what it might take to evolve your growth model for success.
Compare your score from the diagnostic above with the table below.
If you scored in the Competing or Improving range, you’re not alone. Our 2025 State of Life Sciences C-Suite Report shows that 85% of companies are still focused on fighting for share in existing categories.
But as the report also makes clear: That legacy strategy is breaking down in the face of the new healthcare economy.
The companies that will win in the next decade aren’t better—they’re different. And they’re building their businesses around a category they own.
Your score is a signal—and a choice.
Stay tied to the old playbook.
Or build a category the market can’t ignore.
For 15 years, Grey Matter Marketing has helped visionary CEOs create market pull, pricing power, and unstoppable momentum—by making their product the only choice the market is wired to want.
If you’re ready to lead, we’re ready to help.
Because the future belongs to the category creators.